Nick Leschly
2020 - bluebird bio
In 2020, Nick Leschly earned a total compensation of $6.2M as Chief Executive Officer former at bluebird bio, a 53% decrease compared to previous year.
Compensation breakdown
| Option Awards | $2,999,893 |
|---|---|
| Salary | $830,554 |
| Stock Awards | $2,399,800 |
| Other | $11,400 |
| Total | $6,241,647 |
Leschly received $3M in option awards, accounting for 48% of the total pay in 2020.
Leschly also received $830.6K in salary, $2.4M in stock awards and $11.4K in other compensation.
Rankings
In 2020, Nick Leschly's compensation ranked 1,653rd out of 13,090 executives tracked by ExecPay. In other words, Leschly earned more than 87.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,653 out of 13,090 | 87th |
Division Manufacturing | 625 out of 5,621 | 89th |
Major group Chemicals And Allied Products | 226 out of 2,254 | 90th |
Industry group Drugs | 189 out of 1,954 | 90th |
Industry Biological Products, Except Diagnostic Substances | 57 out of 411 | 86th |
Source: SEC filing on May 2, 2022.
Leschly's colleagues
We found two more compensation records of executives who worked with Nick Leschly at bluebird bio in 2020.
News
2seventy bio CEO Nick Leschly's 2023 pay jumps 49% to $9.1M
April 25, 2024
bluebird bio CEO Andrew Obenshain receives $9.3M in 2021
May 2, 2022
2seventy bio CEO Nick Leschly's 2021 pay rises 1% to $6.3M
April 26, 2022
bluebird bio CEO Nick Leschly's 2019 pay falls 45% to $13M
April 27, 2020
bluebird bio CEO Nick Leschly's 2018 pay jumps 173% to $24M
April 23, 2019